SCHEMBL3501667

SCHEMBL3501667

OCc1nc2ccccc2nc1CO

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.53
KDM4E B2RXH2 5/20 0.46
MAPK1 P28482 1/20 0.46
ALDH1A1 P00352 5/20 0.43
GAA P10253 2/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
CYP1A2 P05177 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
PDPK1 O15530 1/20 0.42
NQO2 P16083 2/20 0.42
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
NPC1 O15118 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16424551 0.89 LMNA (0.51) MAPTKDM4EMAPK1ALDH1A1GAA
SCHEMBL21443774 0.85 MAPT (0.43) MAPTKDM4EMAPK1ALDH1A1GAA
SCHEMBL27859566 0.77 TDP1 (0.38) MAPTKDM4EMAPK1ALDH1A1GAA
Water SCHEMBL27878934 0.76 TDP1 (0.37) MAPTKDM4EMAPK1ALDH1A1GAA
SCHEMBL7927501 0.75 ALDH1A1 (0.48) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL8878501 0.75 ALDH1A1 (0.55) MAPTKDM4EALDH1A1GAAHPGD
Phenazine SCHEMBL28805065 0.74 MAPT (0.65) MAPTKDM4EMAPK1ALDH1A1GAA
SCHEMBL18583409 0.74 ALDH1A1 (0.47) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL1506695 0.74 ALDH1A1 (0.46) MAPTKDM4EALDH1A1GAAHPGD
SCHEMBL27337754 0.74 ALDH1A1 (0.46) MAPTKDM4EALDH1A1GAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111825612-B Preparation method of 2, 3-quinoxaline dimethanol-1, 4-dioxide 浦拉司科技(上海)有限责任公司 2021-11-30 CN disclosed
CN-111825612-A Preparation method of 2, 3-quinoxaline dimethanol-1, 4-dioxide 浦拉司科技(上海)有限责任公司 2020-10-27 CN disclosed
US-20160369237-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECH INC (US) 2016-12-22 US disclosed
US-20100184033-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY Lineage Cell Therapeutics, Inc. 2010-07-22 US disclosed
US-20080226601-A1 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods UNIVERSITY OF ROCHESTER (US) 2008-09-18 US disclosed
EP-1903873-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS THE UNIVERSITY OF ROCHESTER (US) 2008-04-02 EP disclosed
US-20080070303-A1 Using myocardial and/or muscle progenitor cells as modeling tool in tissue engineering; regenerative medicine and organ replacement ADVANCED CELL TECHNOLOGY 2008-03-20 US disclosed
WO-2007062198-A1 METHODS TO ACCELERATE THE ISOLATION OF NOVEL CELL STRAINS FROM PLURIPOTENT STEM CELLS AND CELLS OBTAINED THEREBY ADVANCED CELL TECHNOLOGY, INC. (US) 2007-05-31 WO disclosed
WO-2006135602-A2 HERPES VIRUS-BASED COMPOSITIONS AND METHODS OF USE IN THE PRENATAL AND PERINATAL PERIODS UNIVERSITY OF ROCHESTER (US) 2006-12-21 WO disclosed